Hwang, Duhyeong
University of North Carolina at Chapel Hill
5 papers on CoChatORCID 0000-0002-5650-1643
Most cited papers
- Verified
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews
Nanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems
Cited by 699
- Verified
High-capacity poly (2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
Vinod, N., Hwang, D., Azam, S. H., Van Swearingen, A. E. D., Wayne, E., Fussell, S. C., Sokolsky-Papkov, M., Pecot, C. V., & Kabanov, A. V. (2020) · Science Advances
Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery
Cited by 63
- Verified
Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
Alves, V. M., Hwang, D., Muratov, E., Sokolsky-Papkov, M., Varlamova, E., Vinod, N., Lim, C., Andrade, C. H., Tropsha, A., & Kabanov, A. (2019) · Science Advances
Computational Drug Discovery MethodsNanoparticle-Based Drug Delivery
Cited by 56
- Verified
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity
Hwang, D., Dismuke, T., Tikunov, A., Rosen, E. P., Kagel, J. R., Ramsey, J. D., Lim, C., Zamboni, W., Kabanov, A. V., Gershon, T. R., et al. (2021) · Nanomedicine: Nanotechnology, Biology and Medicine
Nanoparticle-Based Drug DeliveryGlioma Diagnosis and Treatment
Cited by 53
- Verified
Novel poly (2-oxazoline) block copolymer with aromatic heterocyclic side chains as a drug delivery platform
Hwang, D., Ramsey, J. D., Makita, N., Sachse, C., Jordan, R., Sokolsky-Papkov, M., & Kabanov, A. V. (2019) · Journal of Controlled Release
Advanced Polymer Synthesis and CharacterizationNanoparticle-Based Drug Delivery
Cited by 40
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free